SBM.V - Sirona Biochem Corp.

Sirona Biochem Corp.

889 West Pender Street
Suite 605
Vancouver, BC V6C 3B2
Canada

http://www.sironabiochem.com

Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Howard J. Verrico M.D.	Founder, Chairman, CEO & Sec.	144k	N/A	1961
Mr. Christopher D. Hopton	CFO & Director	132k	N/A	1966
Dr. Géraldine Deliencourt-Godefroy	Chief Scientific Officer & Director	213.39k	N/A	N/A
Ms. Michelle Seltenrich MBA	VP of Operations	N/A	N/A	N/A
Dr. Brett A. Premack Ph.D.	Scientific Consultant	N/A	N/A	N/A

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada and France. The company develops programs in three areas, including diabetes, anti-inflammatories, and anti-infectives for therapeutics; anti-aging and depigmenting agents in cosmeceuticals; and biological ingredients, such as inducers and adjuvants for the biological development and preservation. It develops a sodium glucose co-transporter inhibitor for the treatment of diabetes, as well as cosmetic skin lightening agents and compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Corporate Governance

Sirona Biochem Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.